Blinded prediction of protein-ligand binding affinity using Amber thermodynamic integration for the 2018 D3R grand challenge 4.


Journal

Journal of computer-aided molecular design
ISSN: 1573-4951
Titre abrégé: J Comput Aided Mol Des
Pays: Netherlands
ID NLM: 8710425

Informations de publication

Date de publication:
12 2019
Historique:
received: 23 06 2019
accepted: 13 09 2019
pubmed: 27 9 2019
medline: 15 8 2020
entrez: 27 9 2019
Statut: ppublish

Résumé

In the framework of the 2018 Drug Design Data Resource grand challenge 4, blinded predictions on relative binding free energy were performed for a set of 39 ligands of the Cathepsin S protein. We leveraged the GPU-accelerated thermodynamic integration of Amber 18 to advance our computational prediction. When our entry was compared to experimental results, a good correlation was observed (Kendall's τ: 0.62, Spearman's ρ: 0.80 and Pearson's R: 0.82). We designed a parallelized transformation map that placed ligands into several groups based on common alchemical substructures; TI transformations were carried out for each ligand to the relevant substructure, and between substructures. Our calculations were all conducted using the linear potential scaling scheme in Amber TI because we believe the softcore potential/dual-topology approach as implemented in current Amber TI is highly fault-prone for some transformations. The issue is illustrated by using two examples in which typical preparation for the dual-topology approach of Amber TI fails. Overall, the high accuracy of our prediction is a result of recent advances in force fields (ff14SB and GAFF), as well as rapid calculation of ensemble averages enabled by the GPU implementation of Amber. The success shown here in a blinded prediction strongly suggests that alchemical free energy calculation in Amber is a promising tool for future commercial drug design.

Identifiants

pubmed: 31555923
doi: 10.1007/s10822-019-00223-x
pii: 10.1007/s10822-019-00223-x
pmc: PMC6899192
mid: NIHMS1540603
doi:

Substances chimiques

Ligands 0
Proteins 0

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

1021-1029

Subventions

Organisme : NIGMS NIH HHS
ID : R01 GM078114
Pays : United States
Organisme : NIGMS NIH HHS
ID : R01 GM107104
Pays : United States

Références

J Med Chem. 2018 Feb 8;61(3):619-637
pubmed: 28749667
J Chem Theory Comput. 2017 Jul 11;13(7):3077-3084
pubmed: 28618232
J Comput Chem. 2004 Jul 15;25(9):1157-74
pubmed: 15116359
Curr Opin Struct Biol. 2011 Apr;21(2):150-60
pubmed: 21349700
J Chem Theory Comput. 2018 Jun 12;14(6):3121-3131
pubmed: 29694035
J Chem Theory Comput. 2019 Dec 3;:null
pubmed: 31714766
Acta Crystallogr D Biol Crystallogr. 2010 Jan;66(Pt 1):12-21
pubmed: 20057044
J Chem Theory Comput. 2014 Jul 8;10(7):2632-47
pubmed: 26586503
J Chem Theory Comput. 2015 Aug 11;11(8):3696-713
pubmed: 26574453
Nucleic Acids Res. 2000 Jan 1;28(1):235-42
pubmed: 10592235
Bioorg Med Chem Lett. 2010 Jul 15;20(14):4060-4
pubmed: 20541404
Bioorg Med Chem Lett. 2010 Apr 1;20(7):2379-82
pubmed: 20188543
Bioorg Med Chem Lett. 2009 Mar 1;19(5):1366-70
pubmed: 19195887
Bioorg Med Chem Lett. 2009 Nov 1;19(21):6131-4
pubmed: 19773165
J Med Chem. 2005 Aug 11;48(16):5175-90
pubmed: 16078837
J Chem Theory Comput. 2013 Sep 10;9(9):3878-88
pubmed: 26592383
J Chem Theory Comput. 2015 Jul 14;11(7):3499-509
pubmed: 26190950
J Comput Aided Mol Des. 2018 Jan;32(1):1-20
pubmed: 29204945
J Pharmacol Exp Ther. 2004 Jan;308(1):268-76
pubmed: 14566006
J Chem Theory Comput. 2012 May 8;8(5):1542-1555
pubmed: 22582031
J Comput Chem. 2009 Aug;30(11):1692-700
pubmed: 19421993
J Comput Chem. 2011 Nov 30;32(15):3253-63
pubmed: 21953558
Nat Rev Drug Discov. 2010 Apr;9(4):273-6
pubmed: 20357802
J Comput Aided Mol Des. 2016 Sep;30(9):651-668
pubmed: 27696240
J Chem Theory Comput. 2017 Dec 12;13(12):6290-6300
pubmed: 29120625
Bioorg Med Chem Lett. 2010 Apr 1;20(7):2375-8
pubmed: 20171097
J Chem Theory Comput. 2017 Jan 10;13(1):42-54
pubmed: 27933808
Nat Methods. 2017 Jan;14(1):71-73
pubmed: 27819658
J Neurosci. 2009 Oct 14;29(41):12787-94
pubmed: 19828790
J Chem Theory Comput. 2014 Aug 12;10(8):3331-44
pubmed: 26588302
J Am Chem Soc. 2015 Feb 25;137(7):2695-703
pubmed: 25625324
J Comput Aided Mol Des. 2019 Jan;33(1):1-18
pubmed: 30632055

Auteurs

Junjie Zou (J)

Department of Chemistry, Stony Brook University, Stony Brook, NY, 11794-3400, USA.
Laufer Center for Physical and Quantitative Biology, Stony Brook University, Stony Brook, NY, 11794-3400, USA.

Chuan Tian (C)

Department of Chemistry, Stony Brook University, Stony Brook, NY, 11794-3400, USA.
Laufer Center for Physical and Quantitative Biology, Stony Brook University, Stony Brook, NY, 11794-3400, USA.

Carlos Simmerling (C)

Department of Chemistry, Stony Brook University, Stony Brook, NY, 11794-3400, USA. carlos.simmerling@stonybrook.edu.
Laufer Center for Physical and Quantitative Biology, Stony Brook University, Stony Brook, NY, 11794-3400, USA. carlos.simmerling@stonybrook.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH